Clinical Correlation of COX-2 and MUC1 Protein Expression in Ovarian Epithelial Carcinoma
Sui Li-hu
Abstract
Sui Li-hu
Abstract
Objective: To investigate correlation of cox-2 and mucl expression in ovarian epithelial carcinoma. Methods: Two monoclonal antibodies, anti-cox-2 and anti-mud and were used in immunohistochemical reaction to measure Cox-2 and mucl paraffin section of 39 ovarian epithelial carcinoma, 11 ovarian tumor and 10 normal controls. And clinical pathological sections of ovarian epithelial-carcinoma were also examined. Results: (1)There was no expression of COX-2 and MUC1 in normal controls, but overexpression in some ovarian epithelial carcinoma. (2) COX-2 overexpression was not correlated with the clinical stages and histo-differentiation and pathological type of ovarian epithelial carcinoma (P0.05), MUC1 overexpression was correlated with the clinical stages and histo-differentiation and pathological type of ovarian epithelial carcinoma .(2)The overexpression of COX-2 and MUC1 was also correlated with prognosis of ovarian epithelial carcinoma (P0.05). Conclusion: COX-2 and MUC1 may be correlated with the occurrence of ovarian epithelial carcinoma, with advanced and metastasis also. The measurement of COX-2 and MUC1 could be used to evaluate the prognosis of ovarian epithelial carcinoma and to assist in chemotherapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate correlation of cox-2 and mucl expression in ovarian epithelial carcinoma. Methods: Two monoclonal antibodies, anti-cox-2 and anti-mud and were used in immunohistochemical reaction to measure Cox-2 and mucl paraffin section of 39 ovarian epithelial carcinoma, 11 ovarian tumor and 10 normal controls. And clinical pathological sections of ovarian epithelial-carcinoma were also examined. Results: (1)There was no expression of COX-2 and MUC1 in normal controls, but overexpression in some ovarian epithelial carcinoma. (2) COX-2 overexpression was not correlated with the clinical stages and histo-differentiation and pathological type of ovarian epithelial carcinoma (P0.05), MUC1 overexpression was correlated with the clinical stages and histo-differentiation and pathological type of ovarian epithelial carcinoma .(2)The overexpression of COX-2 and MUC1 was also correlated with prognosis of ovarian epithelial carcinoma (P0.05). Conclusion: COX-2 and MUC1 may be correlated with the occurrence of ovarian epithelial carcinoma, with advanced and metastasis also. The measurement of COX-2 and MUC1 could be used to evaluate the prognosis of ovarian epithelial carcinoma and to assist in chemotherapy.
Key concepts: Immunohistochemistry, Ovarian carcinoma, MUC1, Pathological, Carcinoma, Epithelial ovarian carcinoma, Ovarian cancer, Pathology